Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000581194 | SCV000689943 | likely benign | Hereditary cancer-predisposing syndrome | 2015-07-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001860085 | SCV002274366 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-07-30 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003150287 | SCV003837610 | uncertain significance | Breast and/or ovarian cancer | 2021-06-25 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004002326 | SCV004827443 | likely benign | Lynch syndrome | 2023-09-17 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001358264 | SCV001553948 | uncertain significance | not provided | no assertion criteria provided | clinical testing | The MSH2 c.-8G>A variant was not identified in the literature nor was it identified in the dbSNP, ClinVar, Clinvitae, GeneInsight – COGR, COSMIC, UMD-LSDB, Insight Colon Cancer Gene Variant Database, Zhejiang Colon Cancer Database, Mismatch Repair Genes Variant Database, Insight Hereditary Tumors Database, the 1000 Genomes Project, the NHLBI GO Exome Sequencing Project or the Exome Aggregation Consortium (August 8th 2016) control databases. While the c.-8G>A variant is located upstream of the translation initiation site, in the 5’ untranslated region, there is currently no evidence to suggest whether this substitution is clinically significant. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. |